Here are some links to information on Lapatinib/Tykerb trials and more info, from the GlaxoSmithKline web site:
About Tykerb Trials
Information about participating sites can be obtained by sending inquiries to the appropriate e-mail address below:
In North America,
lapatinibtrials.northamerica@gsk.com
In Europe,
lapatinibtrials.europe@gsk.com
In the rest of the world,
lapatinibtrials.restoftheworld@gsk.com Information about this and other ongoing clinical trials of Tykerb in breast cancer can be obtained by visiting
http://www.4BreastCancerTrials.com or calling 800-563-7137. Information is also available at
http://www.clinicaltrials.gov, a Web site maintained by the USgovernment.
Link to GlaxoSmithKline web page about Lapatinib/Tykerb:
http://www.gsk.com/ControllerServlet...402&newsid=703